Spring Mountain Capital
Corporate investor
Active
New York, United States
49
14M
33
2.13
13
0.33
9
- Stages of investment
- Areas of investment
Summary
Spring Mountain Capital is the famous VC, which was founded in 2001. The company was established in North America in United States. The main office of represented VC is situated in the New York.
We can highlight the next thriving fund investment areas, such as Clinical Trials, Fitness. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Ziften Technologies, Prevalent Networks, Keen Decision Systems.
The fund was created by Launny Steffens. We also calculated 5 valuable employees in our database.
This Spring Mountain Capital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019. The high activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 35 percentage points more often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Spring Mountain Capital, startups are often financed by Connecticut Innovations, Great Oaks Venture Capital, Female Founders Fund. The meaningful sponsors for the fund in investment in the same round are Connecticut Innovations, StarVest Partners, RRE Ventures. In the next rounds fund is usually obtained by RRE Ventures, National Cancer Institute SBIR Development Center, Ironwood Capital.
Investor highlights
- Check size
- 5M — 15M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 49
- Lead investments
- 13
- Exits
- 9
- Rounds per year
- 2.13
- Follow on index
- 0.33
- Investments by industry
- Health Care (20)
- Biotechnology (14)
- Medical Device (9)
- Medical (8)
- Enterprise Software (7) Show 61 more
- Investments by region
-
- United States (45)
- Canada (3)
- China (1)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 59M
- Group Appearance index
- 0.82
- Avg. company exit year
- 9
- Avg. multiplicator
- 5.24
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Allyx Therapeutics | 01 Jun 2021 | Biotechnology, Health Care, Medical, Life Science | Early Stage Venture | 7M | United States, New York, New Haven |
Genomenon | 08 Mar 2022 | Software, Enterprise Software, Genetics, Medical, Developer Tools | Early Stage Venture | 20M | United States, Ann Arbor, Michigan |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.